JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
HALO - Halozyme Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary HALO Stock
Financials
Financials HALO Stock
Loading...
Loading...
Income Statement
Income Statement HALO Stock
Balance Sheet
Balance Sheet HALO Stock
Cash Flow Statement
Cash Flow Statement HALO Stock
Loading...
Loading...
HALO Financials - Halozyme Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Halozyme Therapeutics, Inc. (HALO)
Financials
Financials of HALO
Loading...
Loading...
Loading...
Loading...
Revenue
$1.396611B
Operating Income
$469.006M
Net Income
$316.889M
Share Count (Basic)
119.84M
Operating Cash Flow
$651.558M
Free Cash Flow
$644.588M
Cash And Short-Term Equivalents
$133.82M
Total Debt
$2.14263B
Annual
Quarterly
Revenue $USD
0
500M
1B
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
100M
200M
300M
400M
500M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
0
100M
200M
300M
400M
Annual
Quarterly
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
100%
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-100M
0
100M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
50%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26